tirzepatide and celiac disease Did you know that one in 100 people in the U.S. are affected by disease? Tune in to our latest podcast episode with Dr. Jose Parungao, gastroenterologist, to learn about this Shifting the Scales: Tirzepatide's Breakthrough

This can help you and your healthcare provider identify patterns and potential causes

For those who've struggled with traditional weight loss methods, these medications can provide the metabolic support needed to make lasting changes

AT contributed in creating the figures and in the critical revision of the manuscript

Disproportionality signals for IGE All five GLP-1RAs had statistically significant reporting odds ratios (RORs) for IGE: Semaglutide: ROR 24.8 Dulaglutide: ROR 14.7 Liraglutide: ROR 13.7 Exenatide: ROR 5.4 Tirzepatide: ROR 18.3 This analysis confirms that these drugs are significantly more likely to be reported in conjunction with IGE compared to other medications